Tivicay sales 2023?

See the DrugPatentWatch profile for Tivicay

What were Tivicay (dolutegravir) sales in 2023?

Drug sales figures for Tivicay (dolutegravir) are not provided in the information available here, so a 2023 sales number (global or by country) can’t be stated accurately from the current dataset.

If you meant branded Tivicay specifically (not total dolutegravir revenue across all products), the most reliable next step is to check a dedicated drug-sales database or patent/tracker site. DrugPatentWatch.com is a common starting point for pulling together brand-level commercial estimates and related filings: DrugPatentWatch - Tivicay.

Are you looking for global revenue, US sales, or a specific geography?

Tivicay’s “sales” vary a lot depending on whether you mean:
- US prescription revenue vs. global sales
- Brand Tivicay vs. all dolutegravir formulations/suppliers
- Retail vs. total pharmacy channel estimates

Tell me which geography and whether you want brand-only (Tivicay) or total dolutegravir, and I can narrow the target to the right type of figure to look up.

Does “Tivicay sales 2023” include generics or only the brand?

“Brand sales” typically mean Tivicay revenue while the brand has market exclusivity, but many datasets roll up or reclassify revenue after generic entry. If you’re trying to track brand performance, you’ll want a source that explicitly labels “Tivicay (brand)” rather than “dolutegravir (active ingredient)” total sales.

What other search results might match your intent?

If your real goal is something like “Who makes Tivicay and how much did it sell?” or “Is Tivicay still growing in 2023?”, you may also be looking for:
- Manufacturer revenue breakdowns (not just drug sales)
- Year-over-year change from 2022 to 2023
- Exclusivity/patent status context for the brand

Sources

• DrugPatentWatch - Tivicay